Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. (Record no. 17201702)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02090 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515075519.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200711s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0270-9139 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1002/hep.21791 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Schaefer, Martin |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20071130 |
| 245 00 - TITLE STATEMENT | |
| Title | Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Hepatology (Baltimore, Md.) |
| Date of publication, distribution, etc. | Oct 2007 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 991-8 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Controlled Clinical Trial; Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antidepressive Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antiviral Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Depression |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis C, Chronic |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon alpha-2 |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-alpha |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Logistic Models |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mental Disorders |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polyethylene Glycols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Proteins |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ribavirin |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Risk Factors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Substance-Related Disorders |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hinzpeter, Axel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mohmand, Ariane |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Janssen, Gesa |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pich, Maurice |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schwaiger, Markus |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sarkar, Rahul |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Friebe, Astrid |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Heinz, Andreas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kluschke, Michael |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ziemer, Marlene |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gutsche, Juri |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Weich, Viola |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Halangk, Juliane |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Berg, Thomas |
| 773 0# - HOST ITEM ENTRY | |
| Title | Hepatology (Baltimore, Md.) |
| Related parts | vol. 46 |
| -- | no. 4 |
| -- | p. 991-8 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/hep.21791">https://doi.org/10.1002/hep.21791</a> |
| Public note | Available from publisher's website |
No items available.